Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) class II genes are expressed constitutively in only a few cell types, but they can be induced in the majority of them, in particular by interferon-gamma (IFN-gamma). The MHC class II transactivator gene CIITA is defective in a form of primary MHC class II deficiency. Here it is shown that CIITA expression is controlled and induced by IFN-gamma. A functional CIITA gene is necessary for class II induction, and transfection of CIITA is sufficient to activate expression of MHC class II genes in class II-negative cells in the absence of IFN-gamma. CIITA is therefore a general regulator of both inducible and constitutive MHC class II expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of PD-L1 and MHC II, which may cause exhaustion by binding to T-cell programmed cell death protein 1 (PD-1) and lymphocyte activation gene 3 (LAG-3), respectively, is regulated by tumor interferon (IFN) signaling.”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [27]
Citations
Cites
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
A Single Phosphotyrosine Residue of Stat91 Required for Gene Activation by Interferon-γ
Shuai, K., Stark, G. R., Kerr, L. M., & Darnell, J. E. (1993) · Science · doi:10.1126/science.7690989 · Cited by 802
Activation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775
Collins, T., Korman, A. J., Wake, C. T., Boss, J. M., Kappes, D. J., Fiers, W., Ault, K. A., Gimbrone, M. A., Strominger, J. L., & Pober, J. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4917 · Cited by 585
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Benoist, C., & Mathis, D. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003341 · Cited by 457
Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Stark, G. R., & Kerr, I. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06106.x · Cited by 411
Detection of a novel human class II HLA antigen
Watson, A. J., DeMars, R., Trowbridge, I. S., & Bach, F. H. (1983) · Nature · doi:10.1038/304358a0 · Cited by 376
Cited by
Items 701–800 of 899
Kaushal, H., Kartaskar, R. S., Chiplunkar, T., Yadav, P. D., Awate, P., Potdar, V. A., Khalipe, M. M., Saraf, C. K., Shete, A. M., Sahay, R. R., et al. (2024) · Viral Immunology · doi:10.1089/vim.2023.0107 · Cited by 5
“IFN-g enhances the expression of major histocompatibility complex (MHC) I and MHC II in the nearby viral-infected cells and APCs, respectively (Schroder et al., 2004; Steimle et al., 1994).”
Lee, W., Moon, H.-R., Choi, H., Lee, H. J., Kim, Y., Kim, H. J., Yun, Y., Kwon, M., & Hong, S. W. (2025) · npj Science of Food · doi:10.1038/s41538-025-00593-7 · Cited by 8
T lymphocyte-derived TNF and IFN-γ repress HFE expression in cancer cells
Reuben, A., Godin-Ethier, J., Santos, M. M., & Lapointe, R. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.029 · Cited by 11
Meissner, R., Wixler, V., Wulfert, F. P., Jacob, J. C., Hale, B. G., Robeck, T., Masemann, D., Boergeling, Y., & Ludwig, S. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.100741 · Cited by 5
“Both MHC class II expression and NOS induction are known to be stimulated in response to IFN-g , 47,48 which is in good agreement with the increased levels of virus-derived IFN-g on day 3, as shown in Figure 3A.”
MHC Class II deficiency: Definition of a New Complementation Group
Villard, J., Mach, B., & Reith, W. (1997) · Immunobiology · doi:10.1016/s0171-2985(97)80046-0 · Cited by 5
Rammensee, H., Bachmann, J., & Stevanović, S. (1997) · Molecular biology intelligence unit · doi:10.1007/978-3-662-22162-4_2 · Cited by 5
Gu, L., Yue, J., Zheng, Y., Zheng, X., Wang, J., Wang, Y., Li, J., Jiang, Y., & Jiang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055892 · Cited by 5
“Moreover, IFN-c has been documented to induce MHC II expression on the tumor cell surface [28], resulting in enhanced recognition by the immune system.”
BackgroundHall, H. T. L., Petrovic, J., & Höglund, P. (2004) · European Journal of Immunology · doi:10.1002/eji.200425074 · Cited by 5
CIITA B-cell-specific promoter suppression in MHC class II-silenced cell hybrids
Lennon, A., Ottone, C., Rosemblatt, M. S., Fellous, M., Bono, M.-R., & Alcaïde‐Loridan, C. (1998) · Immunogenetics · doi:10.1007/s002510050433 · Cited by 5
“hybrids, human CIITA mRNA expression was not detected, which is probably explained by the segregation of human chromosome 16-encoding CIITA (Steimle et al. 1994).”
BackgroundWillheim, M., Silacci, P., Gessl, A., Spittler, A., Szépfalusi, Z., Samorapoompichit, P., Agis, H., Mayr, W. R., Scheiner, O., Förster, O., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251134 · Cited by 5
Cao, H., Xiang, Y., Zhang, S., Chao, Y., Guo, J., Ho, J. W. K., Huang, Y., Liu, P., & Sugimura, R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.14.520176 · Cited by 5
“The dimerized phospho-STAT1 binds to promoters of interferon-stimulated genes (ISGs) (15).”
BackgroundButeyn, N. J., LaMantia, S. J., Burke, C. G., Sartori, V. J., Gardner, E., DeBruine, Z. J., Kamarudin, D., Chandler, D. P., Monovich, A. C., Perez, M. W., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.14.594150 · Cited by 5
Bao, L., Zhu, M., Luo, M., Kumar, A., Peng, Y., Xing, C., Wang, Y., & Luo, W. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188801 · Cited by 5
“Unlike ubiquitously expressed MHC-I, MHC-II molecules are predominantly expressed in professional antigen-presenting cells (APCs), including dendritic cells, B cells, and macrophages, which are induced by the class II transactivator (CIITA) and interferon-γ (IFN-γ ) (17–19).”
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes
Lilljebjörn, H., Peña‐Martínez, P., Thorsson, H., Henningsson, R., Rissler, M., Landberg, N., Puente‐Moncada, N., von Palffy, S., Rissler, V., Staněk, P., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66546-6 · Cited by 9
“…this difference, we speci fi cally studied the expression of the human leukocyte antigen (HLA) genes encoding MHC-II components, together with genes encoding MHC-I components, non-classical HLA genes, and the MHC-II master regulator CIITA 37 in AML immature cells from the scRNA-seq data (Fig.”
InfluentialInnate immunity: current understandings and future perspectives
Zou, C., Ma, T., Li, J., & Zhou, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02920-0 · Cited by 11
Chen, Y., Yang, H., Wu, X., Liu, Z., Chen, Y., Wei, Q., Lin, J., Yu, Y., Tu, Q., & Li, H. (2024) · Genes · doi:10.3390/genes15111418 · Cited by 4
“CIITA is a non-DNA-binding transcriptional coactivator essential for both constitutive and IFN-γ - inducible MHC II expression [51,52].”
Shen, S., Mohan, A. A., Hotchkiss, K. M., Cook, S. L., Patel, K., Moelker, E., Puviindran, B. J., Gonzalez, A. T., Zaidi, S. E., Spellicy, S. E., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012532 · Cited by 8
Cao, Y., Feng, R., Jiao, L., Bu, L., Tian, J., Wan, H., & Guan, Y. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102312 · Cited by 3
Cui, W., Wang, Y., Guo, J., & Zhang, Z. (2023) · Medicine · doi:10.1097/md.0000000000032808 · Cited by 5
“[37] This property of pancreatic adenocarcinoma is due in part to the fact that the tumor has low mutational load or neoantigen expression, with very weak immunogenicity and inability to induce activation of effector T cells.[38] Because of its rich connective tissue stroma, pancreatic adenocarcinoma can impede T cell…”
BackgroundLee, Y. J., Seok, S. H., Lee, N. Y., Choi, H. J., Lee, Y. W., Chang, H. J., Hwang, J.-Y., On, D. I., Noh, H. A., Lee, S., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.03.008 · Cited by 5
“The cytokine interferon-g (IFN-g) can induce MHCII in many different cell types, leading to antigen presentation to T cells and immune activation.(21,22) To examine IFN responses in the lung, the authors investigated the expression of the stimulator of interferon genes (STING), which is activated by cytosolic DNA rele…”
Jansa, P., & Hatina, J. (2003) · DNA and Cell Biology · doi:10.1089/104454903321112505 · Cited by 4
Evidence for discoordinate regulation of the HLA‐DPB1 gene
Coiras, M., Alvarez, A. M., Díaz‐Gil, G., Arroyo, J., & Sánchez‐Pérez, M. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.600606.x · Cited by 4
Expression and Purification of JAK1 and SOCS1 for Structural and Biochemical Studies
Liau, N. P. D., & Babon, J. J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7568-6_21 · Cited by 6
Assessment of IFN-γ and granzyme-B production by in “sitro” technology
Galassi, C., Manic, G., Musella, M., Sistigu, A., & Vitale, I. (2020) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.08.001 · Cited by 4
Role of muIP-10 in interferon-γ induction of Ia in rat astrocytes
Vanguri, P., Cho, S. Y., & Chi, C.-M. (1996) · Molecular Immunology · doi:10.1016/s0161-5890(96)00057-0 · Cited by 4
Accolla, R. S., Tosi, G., Sartoris, S., & Barbaro, A. D. L. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00231-2 · Cited by 4
Iwata, M., Suzuki, Y., Imai, Y., Ono, Y., & Sawa, M. (2001) · Japanese Journal of Ophthalmology · doi:10.1016/s0021-5155(00)00296-3 · Cited by 4
Class II transactivator: is it a master switch for MHC class II gene expression?
Chang, C., Roys, S., & Gourley, T. S. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00230-0 · Cited by 4
Celada, A., Gil, M. P., McKercher, S. R., & Maki, R. A. (1996) · Biochemical Journal · doi:10.1042/bj3130737 · Cited by 5
Kotliar, D., Lin, A. E., Logue, J., Hughes, T. K., Khoury, N. M., Raju, S. S., Wadsworth, M. H., Chen, H. M., Kurtz, J. R., Dighero-Kemp, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.12.148957 · Cited by 4
“While IFNγ typically up-regulates MHC-II gene and protein expression (Steimle et al., 1994), we observed decreased MHC-II on monocytes despite elevated IFNγ mRNA levels in T cells (Figure S6A) and widespread IFNγ transcriptional response in monocytes (Figure S6B).”
BackgroundInfluentialSARS-COV-2 NSP5 Antagonizes MHC II Expresion by Subverting Histone Deacetylase 2Preprint
Taefehshokr, N., Lac, A., Vrieze, A. M., Dickson, B. H., Guo, P. N., Jung, C., Blythe, E. N., Fink, C., Aktar, A., Dikeakos, J. D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.10.528032 · Cited by 4
“MHC II expression is driven by type II interferon signaling [30].”
BackgroundThe RNA Binding Protein, HNRNPA2B1, Regulates IFNG Signaling in MacrophagesPreprint
Salih, M. M., Weindel, C. G., Malekos, E., Sudek, L. A., Katzman, S. J., Mabry, C. J., Coleman, A. K., Azam, S., Watson, R. O., Patrick, K. L., et al. (2023) · SSRN Electronic Journal · doi:10.1101/2023.10.12.562050 · Cited by 4
Janas, P. P., T’Jonck, W., Burgess, M. O., Reck, M., Chauché, C., Vermeren, M., Lucas, C. D., Bain, C. C., Illingworth, R. S., Roberts, E. W., et al. (2025) · Allergy · doi:10.1111/all.16683 · Cited by 5
Jin, Y., Zheng, W., Zhang, R., Hou, S., Luo, C., Ren, P., Pan, D., Luo, C., & Zeng, Z. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03673-y · Cited by 3
“Within the tumor microenvironment (TME), HLA-II expression on cancer cells can be induced by cytokines such as IFN-γ [3, 8].”
Monti, M., Picinoli, S., Bozzola, A. M., Ferrari, M., Bugatti, M., Pezzali, I., Carlomagno, M., Carta, G., Orlandi, M., Lora, G., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012222 · Cited by 5
Sligar, C., Sluyter, R., & Ooi, L. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03764-9 · Cited by 5
kim, S. H., Park, S., & Lee, S. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.03.004 · Cited by 3
Immune Cell Networks Uncover Candidate Biomarkers of Melanoma Immunotherapy Response
Vo, D. H. T., McGleave, G., & Overton, I. M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060958 · Cited by 4
“Higher expression of the CIITA transcription factor correlates with lower risk; CIITA functions to upregulate MHC genes, and so lower CIITA expression might facilitate immune evasion [81,104].”
BackgroundMAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer
Barbeau, L. M. O., Beelen, N. A., Savelkouls, K. G. M., Keulers, T. G., Wieten, L., & Rouschop, K. M. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316716 · Cited by 4
“To test whether MAP1LC3C expression directly controls HLA class II expression, MAP1LC3C deficient SW900 (LUSC) cells were generated and assessed for MAP1LC3C mRNA (Fig 3A Importantly, HLA class II expression on cancer cells increases due to IFNγ signaling [9,15].”
CD4+ T cell–innate immune crosstalk is critical during Staphylococcus aureus craniotomy infection
Kak, G., Roy, Z. A. V., Fallet, R. W., Korshoj, L. E., & Kielian, T. (2025) · JCI Insight · doi:10.1172/jci.insight.183327 · Cited by 3
Chen, L., Zhang, M., Wang, X., Liu, Y., Bian, J., Yan, D., & Yin, W. (2021) · Steroids · doi:10.1016/j.steroids.2021.108915 · Cited by 3
Liu, W. Y., Lien, Y.-H., Lee, P., Chan, T., Wang, L., Yang, C.-R., Ho, M., Chen, J.-R., Ku, C., & King, C. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.03.047 · Cited by 3
Heredia, M., Charrout, M., Klomberg, R. C. W., Aardoom, M. A., Jongsma, M., Kemos, P., Haaften, D. H. H.-V., Tuk, B., van Berkel, L. A., Folly, B. B., et al. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.09.004 · Cited by 5
Cellular and molecular dynamics in the lungs of neonatal and juvenile mice in response to E. coli
McGrath‐Morrow, S. A., Venezia, J., Ndeh, R., Michki, S. N., Perez, J., Singer, B. D., Cimbro, R., Soloski, M. J., & Scott, A. L. (2023) · eLife · doi:10.7554/elife.82933 · Cited by 3
“lower numbers of IFNg-producing CD4 T cells (24-26).”
BackgroundRevel, M. (1997) · Growth factors and cytokines in health and disease · doi:10.1016/s1874-5687(97)80034-1 · Cited by 4
A Defective Viral Superantigen-Presenting Phenotype in HLA-DR Transfectants Is Corrected by CIITA
Azar, G. A., Sékaly, R., & Thibodeau, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7548 · Cited by 3
Schmidt, B. J., Carter, S. S., Berry, D. E., & Blanck, G. (1996) · Cancer Letters · doi:10.1016/s0304-3835(96)04487-4 · Cited by 3
Silva, A. M., Bottrel, R. L. A., & Reis, L. F. L. (1999) · Cytokine · doi:10.1006/cyto.1999.0493 · Cited by 4
CIITA induces expression of MHC-I and MHC-II in transmissible cancersPreprint
Ong, C. E. B., Cheng, Y., Siddle, H. V. T., Lyons, A. B., Woods, G. M., & Flies, A. S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.14.452299 · Cited by 3
Pingen, M., Hughes, C. E., Medina‐Ruiz, L., Mathie, H. A., Barrie, J. A., Hansell, C. A. H., Bartolini, R., MacLeod, M. K. L., & Graham, G. J. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.05.005 · Cited by 3
Progress and Perspectives in Allogeneic Cell‐Based Pulp Regeneration
Chen, Y., Hu, M., Lee, Y. L., Chen, L., Lin, S., Li, X., Xu, J., & Zhang, C. (2025) · International Endodontic Journal · doi:10.1111/iej.70080 · Cited by 3
Kong, X., Wang, B., Wu, X., Cho, H., Fu, W., Li, Q., Zhang, R., Nasri, U., Zheng, M., Wu, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69975-z · Cited by 4
“IFN-γ induces MHCII expression by antigen-presenting cells and other cells 45 ,but theimpactof IFN-γ onregulation of tissueTm subsets in cGVHD remains unclear.”
Noh, H., Hua, Z., Chrysinas, P., Shoemaker, J. E., & Gunawan, R. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04046-2 · Cited by 2
Genome Editing of Pluripotent Stem Cells for Adoptive and Regenerative Cell Therapies
Blassberg, R. A. (2022) · GEN Biotechnology · doi:10.1089/genbio.2021.0010 · Cited by 3
The necessary role of an efficient tumor immunotherapy by MHC II expression on amateur APCs
Zhong, J., Lin, X., & Hu, H. (2024) · Malignancy Spectrum · doi:10.1002/msp2.29 · Cited by 4
Optimizing Outcomes in Heart Transplantation: The Role of High‐Intensity Statin Therapy
Ghavamikia, N., Saffarfar, H., Seifdavati, B., Jamali, M., Izadidehkordi, S., Pakmehr, S., Aghabali, M., Jahani, N., Ali‐Khiavi, P., Soleimanian, A., et al. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70070 · Cited by 2
Marchenko, S., Goernitz, N., Zoern, W. A., Joosten, M., Hoffmann, I., Sehouli, J., Niedobitek, G., Denkert, C., Sinn, B. V., Kolb, S., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2794 · Cited by 2
Shao, R., Liu, X., Ding, Y., Chen, X., Gao, R., He, J., & Wang, Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1019 · Cited by 2
“In addition, MHCⅡ expression can be induced in the majority of cells by numerous cytokines, especially by interferon-γ (IFN-γ ) (26).”
Molecular characterization of chicken class II transactivator gene
Brujeni, G. N., & Khosravi, M. (2014) · Immunogenetics · doi:10.1007/s00251-014-0810-5 · Cited by 2
(2008) · Springer eBooks · doi:10.1007/978-3-540-33395-1_1 · Cited by 2
Sharif, P. M., Khoshbin, A. P., Nasrollahzadeh, E., Keshavarz‐Fathi, M., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00003-7 · Cited by 8
Gao, J., De, B. P., & Banerjee, A. K. (2002) · Viral Immunology · doi:10.1089/088282402317340251 · Cited by 2
“In addition, IFN-g –induced MHC class II expression requires CIITA at a downstream step of the pathway (1,2,18,26,27).”
Manipulation of Macrophage Activities Using Liposomes
Honing, H., van Rooijen, N., & van den Berg, T. K. (2000) · Journal of Liposome Research · doi:10.3109/08982100009031105 · Cited by 3
Karasin, A. I., Macvilay, S., HART, M. N., & Fábry, Z. (1998) · Endothelium · doi:10.3109/10623329809072195 · Cited by 3
Psifidi, A., Kranis, A., Rothwell, L. M., Bremner, A., Russell, K., Robledo, D., Bush, S. J., Fife, M. S., Hocking, P. M., Banos, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.14.040832 · Cited by 2
Schwarz, K., Fugmann, S. D., Pannicke, U., & Bartram, C. R. (1999) · Springer eBooks · doi:10.1007/978-3-662-07865-5_2 · Cited by 3
NRF2 inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infectionPreprint
Pham, L. K., Cervantes, M. M., Lim, P. N., Dubey, D., Tufts, A., Shinkawa, T., Behar, S. M., & Rothchild, A. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.16.670319 · Cited by 2
Furuta, K., Miyazato, K., Kobata, K., Ishikawa, K., & Kaito, C. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152453 · Cited by 1
Raymond, M., Balthazard, R., Zahn, A., Silva‐Barrios, S., Hammami, A., Majdoubi, A., Lee, J. S., Connolly, A., Sabourin, A., Galbas, T., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf273 · Cited by 1
The D-6 Mouse Monoclonal Antibody Recognizes the CD74 Cytoplasmic Tail
Genève, L., Gauthier, C., & Thibodeau, J. (2014) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2013.0078 · Cited by 1
“(40) In addition, we tested RAW CIITA cells super-transfected with either hIip33 (RAW CIITA hIip33) or hIip35 (RAW CIITA hIip35).”
An emerging role of CD74 in thyroid follicular cells in Hashimoto´s thyroiditis
Sacristan-Gomez, P., Serrano-Somavilla, A., de la Blanca, N. S., Álvarez-Rodríguez, A., Martínez-Parra, E., Sampedro-Nuñez, M. A., Sebastián‐Valles, F., Marazuela, M., & Martínez‐Hernández, R. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118945 · Cited by 2
Gerede, A., Oikonomou, E., Gkaitatzi, F., Danavasi, M., Papasozomenou, P., Potiris, A., Stavros, S., Kourti, V., Domali, E., Koutlaki, N., et al. (2026) · Biomolecules · doi:10.3390/biom16030402 · Cited by 2
“…of forkhead box protein O1 (FOXO1)–BCL2-interacting mediator of cell death (BIM) signaling and sustained chronic inflammation through cluster of differentiation CD4 + T cells and human leukocyte antigen (HLA) class II–interferon gamma (IFN-γ ) feedback [80], leading to T-cell exhaustion [81].”
Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions
Ng, B. D., Whelan, C., Alkon, N., Kurowski, A., Jonak, C., & Brunner, P. M. (2026) · Experimental Dermatology · doi:10.1111/exd.70240 · Cited by 2
“In line, we observed upregulation of antigen presentation genes in the KCs of esMF samples, which is well known to occur following IFN-γ stimulation [56, 57].”
Pham, L. K., Cervantes, M. M., Lim, P. N., Dubey, D., Tufts, A., Mitchell, M. C., Shinkawa, T., Behar, S. M., & Rothchild, A. C. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117397 · Cited by 5
“45 In contrast, WT and NRF2 −/− mexAMs expressed equivalent levels of surface MHC II after IFN β stimulation (Figure 4B).”
He, F., Guo, R., Du, X., Lu, Z., Weng, J., & Lin, W. (2007) · Transplant Immunology · doi:10.1016/j.trim.2006.12.002 · Cited by 1
Naamane, H., Ailal, F., Abidi, O., Jeddane, L., Najib, J., Barakat, A., & Bousfiha, A. (2011) · BMC Proceedings · doi:10.1186/1753-6561-5-s1-p88 · Cited by 1
Detection of gene expression and sequence analysis of chicken class II trans activator (CIITA).
Khosravi, M., & Nikbakhat, G. (2014) · Iranian Journal of Veterinary Medicine · doi:10.22059/ijvm.2013.36289 · Cited by 1
“CIITA is expressed in a constitutive manner on macrophages, B lymphocytes, and dendritic cells (Muhlethaler et al., 1997) although its expression can be induced on various tissues by IFN-|γ| (Steimle et al., 1994).”
BackgroundKomolafe, A., Ally, M. M. T. M., van Tonder, J. J., & Greeff, O. B. W. (2015) · South African Family Practice · doi:10.1080/20786190.2014.995919 · Cited by 1
Cathepsin B is a Negative Regulator in Pulmonary Aspergillosis
Mittal, A., Mandal, T., Bindal, R., & Dabur, R. (2011) · International Journal of Bioscience Biochemistry and Bioinformatics · doi:10.7763/ijbbb.2011.v1.23 · Cited by 1
Tran, T. H., Làn, P. T., Khang, T. H., & Luong, V. H. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.8052 · Cited by 1
“Finally, IFN-γ contributes to the antigen processing and presentation and thus stimulates the cell-mediated immunity by upregulation of MHC molecules [37], [38], [39].”
BackgroundJiang, Y., Yao, J., Yao, Z., Huang, Y., Li, Z., Fan, Z., Zhou, Y., Li, Z., Li, Z., & Xu, B. (2023) · Medical Oncology · doi:10.1007/s12032-023-02123-5 · Cited by 1
Nagy, Z. A., & Vidović, D. (1995) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60934-3 · Cited by 1
Characterization of the human NLR protein NLRC5
Neerincx, A. (2013) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 1
Origin and Processing of MHC Class II Ligands
Watts, C. K. W., & Manoury, B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.06011-2 · Cited by 1
CD4 T Cell Immunity to Viral Infection
Swain, S. L., Strutt, T. M., & McKinstry, K. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14026-3 · Cited by 1
The Major Histocompatibility Complex Genes and their Transcriptional Regulation
Abdulkadir, S. A., Casolaro, V., Schwiebert, L. S., Song, Z., & Ono, S. J. (1996) · Springer eBooks · doi:10.1007/978-1-4684-6462-7_2 · Cited by 2
Barry, A., McNulty, M. T., Jia, X., Gupta, Y., Dêbiec, H., Luo, Y., Nagano, C., Horinouchi, T., Jung, S., Colucci, M., et al. (2022) · medRxiv · doi:10.1101/2022.09.13.22279644 · Cited by 1
“It is also in close proximity to CIITA , a master transcription factor of HLA class II genes 40 and Dexamethasone Inducible Transcript ( DEXI), a glucocorticoid-induced gene 41 .”
BackgroundMohammed, A., Solomon, B. D., Slepicka, P. F., Hubka, K. M., Nguyen, H. D., Wang, W., Arreola, M., Chavez, M., Yeh, C. Y., Kim, D. K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.02.510339 · Cited by 1
Zindl, C. L., Wilson, C. G., Chadha, A. S., Cai, B., Harbour, S. N., Nagaoka-Kamata, Y., Hatton, R. D., Gao, M., Figge, D. A., & Weaver, C. T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.03.539269 · Cited by 1
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancersPreprint
Pineda, J. M. B., & Bradley, R. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.10.548412 · Cited by 1
“2B; (Glimcher & Kara, 1992; Masternak et al., 2000; Steimle et al., 1993, 1994).”
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancersPreprint
Pineda, J. M. B., & Bradley, R. K. (2023) · eLife · doi:10.7554/elife.89017.1 · Cited by 2
Temporal regulation of human reactive astrocytes reveals their capacity for antigen presentationPreprint
Hill, E. J., Sojka, C., Sampson, M. M., Wang, H. V., King, A. T., Sing, A. D., Hub, E. B. O., Faúndez, V., & Sloan, S. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.26.661787 · Cited by 1
“Other work has shown that OPCs are also capable of expressing MHCII in disease settings (11, 50), suggesting that non-microglial antigen presentation may be more widespread than previously appreciated.”
T cell immunity to Kaposi’s sarcoma-associated herpesvirus latent proteins
Sabbah, S. (2012) · University of Birmingham Institutional Research Archive (University of Birmingham)
Understanding the mechanism of cure in testicular cancer
Pearce, H. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
The Effect of MHC Class II Transactivator (CIITA) on the Growth and Metastasis of Breast Tumors.
Martin, B. K. (1998) · Defense Technical Information Center (DTIC) · doi:10.21236/ada353890
“Hypothesis/Purpose CIITA has been shown in many systems to induce several genes involved in the MHC class II antigen presentation pathway (44-47).”
BackgroundBoss, J. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6675
Effect of Some Herbal Plant Extracts on the Activation of Dendritic Cells
Kim, D.-S., Park, J., Cho, H., Joo, W., & Yee, S.-T. (2007) · Journal of Life Science · doi:10.5352/jls.2007.17.3.427
Genetic studies of complex autoimmune disease
Gyllenberg, A. (2014) · Figshare
Genetic analysis of candidate susceptibility genes for type 1 diabetes
Asad, S. (2012) · Figshare
Metadata
- Authors
- Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B.
- Affiliations
- University of Geneva (CH)
- Jeantet Laboratory of Molecular Genetics, Department of Genetics and Microbiology, University of Geneva Medical School, CH-1211 Geneva 4, Switzerland.
- INSERM U132, Hôpital des Enfants Malades, 15015 Paris, France.
- Venue
- Science
- Published
- 1994-07
- Volume
- 265
- Issue
- 5168
- Pages
- 106-109
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2060320549
- Cited by
- 898
- References
- 29
- Citations by year
- 2026: 33 · 2025: 35 · 2024: 39 · 2023: 49 · 2022: 35 · 2021: 32 · 2020: 25 · 2019: 20 · 2018: 22 · 2017: 19 · 2016: 27 · 2015: 21 · 2014: 18 · 2013: 13 · 2012: 29
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MHC class II expression, interferon-gamma, CIITA, MHC class II deficiency, gene expression regulation, transcriptional activation
- MeSH terms
- Histocompatibility Antigens Class II, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 16, Fibroblasts, Gene Expression Regulation, Genes, MHC Class II, Humans, Interferon-gamma, Models, Genetic, Nuclear Proteins, RNA, Messenger, Transfection, Tumor Cells, Cultured, Trans-Activators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.